nephrons undergo hyperfiltration and hypertrophy, which are associated with glomerular capillary hypertension, synthesis of cytokines and growth factors, and extracellular acute renal failure. Two groups of animals were studied according to the experimental procedure mentioned ear-matrix accumulation, which lead to glomerulosclerosis [6] . Thus, it is well known that in mesangial cells, mechanical lier in this article. Rats were followed for seven days and on the first, second, third, and seventh day, 0.5 ml of stress leads to matrix accumulation by means of the induction of transforming growth factor-␤1 (TGF-␤1) [7] , blood was obtained from the tail vein for serum creatinine measurement. Conventional histology was per-which is recognized as a key fibrogenic cytokine involved in chronic transplant nephropathy [8] .
formed on day 7. One of the groups was a control (ischemic, N ϭ 11), and the other received oral UR-12670 Platelet-activating factor (PAF) is a potent phospholipid mediator involved in acute inflammatory and im-daily (UR-treated, N ϭ 10).
For chronic experiments, animals were divided into mune responses [9] . Our group has previously shown that treatment with PAF receptor antagonists protects five groups. Two were control groups: (a) the single kidney group (SK), uninephrectomized rats with a left non-from warm renal [10] and cold [11] ischemia/reperfusion injury in rat kidney, as well as from delayed graft function ischemic kidney (N ϭ 7), and (b) the single ischemic kidney group (SIK), uninephrectomized rats with left in cadaveric kidney transplantation [12] . However, the role of PAF in the development of chronic nephropathy warm renal ischemia (N ϭ 12). (c) One was a shortterm treatment group of uninephrectomized rats with induced by ischemia/reperfusion injury has not been previously studied. Interestingly, it has been recently de-left warm renal ischemia and UR-12670 administration from day 0 until the seventh day post-ischemia and then scribed that PAF induces the synthesis of extracellular matrix proteins by mesangial [13] and tubular epithelial followed for 52 weeks (UR 0-7; N ϭ 12). Finally, two were long-term UR-12670-treated groups: (d) uni-cells [14] , suggesting a role for PAF in glomerulosclerosis and interstitial fibrosis.
nephrectomized rats with left warm renal ischemia and UR-12670 administration from day 0 until the 52nd week The aim of this work was to evaluate, in the absence of allorecognition, whether or not the administration of (UR 0-E; N ϭ 10), and uninephrectomized rats with left warm renal ischemia in which drug administration was the oral PAF receptor antagonist UR-12670 could prevent the development of chronic nephropathy induced by warm delayed for eight days after ischemia and then given until the 52nd week (UR 8-E; N ϭ 12). Additional rats were renal ischemia/reperfusion injury associated with nephron mass reduction. We also evaluated whether this effect evaluated in the SK, SIK, and UR 0-E groups to allow histological studies at 16 and 32 weeks (N ϭ 5 rats each). could be due to the protection against post-ischemic acute renal failure, by giving a short course of UR-12670, or to Before the experiment and every four weeks after the surgical procedure, all animals were placed in metabolic the interference in PAF-mediated mechanisms potentially involved in long-term tissue remodeling and fibrosis, by cages in order to collect a 24-hour urine sample. Animals were weighed at the same intervals, and 0.5 ml of blood a chronic treatment with UR-12670. from the tail vein was obtained.
METHODS

Platelet-activating factor antagonist administration Experimental design
UR-12670 (Uriach Laboratories, Barcelona, Spain) is a potent, orally active, and highly selective PAF receptor Male Sprague-Dawley rats (250 to 300 g body wt) were used in this study. Animal care and interventions were antagonist that has been tested in several in vivo models [15, 16] . The chemical name of UR-12670 is 1-[[1-(3,3-conducted in accordance with the guidelines of the European Community Committee on care and use of labora-diphenylpropanoyl)-4-piperidyl]methyl]-1-H-2-methylimidazo [4,5-c] pyridine. It has a molecular weight of tory animals and good laboratory practice. After intramuscular anesthesia with a mixture of ketamine (75 mg/kg), 438.57 and is a hydrosoluble compound with a 100% oral bioavailability [15] . atropine (0.05 mg/kg), and diazepam (5 mg/kg), the animal was placed on a warming pad in order to maintain UR-12670 was administered intravenously at 10 mg/kg five minutes before reperfusion and was later given orally body temperature at the physiological range. A medial laparotomy was performed, and left kidney normother-at 20 mg/kg by daily gavage. mic ischemia was induced by renal pedicle occlusion for Biochemical data 60 minutes using a nontraumatic clamp. Simultaneously, right nephrectomy was done, and finally, reperfusion was Proteinuria (mg/24 hr) was determined every four weeks by the Ponceau method (Bayer Diagnó sticos, Ma-confirmed visually after clamp removal. Then the animals were housed in a room kept at constant temperature with drid, Spain). Serum and urine creatinine (mg/dl) were determined in the same intervals by Jaffe's reaction on a 12-hour dark/12-hour light cycle. Rats had free access to tap water and were fed a standard rodent diet.
an autoanalyzer (Beckman Instruments, Palo Alto, CA, USA), and creatinine clearance (ml/min/100 g body wt) Acute experiments were performed to assess the protective effect of oral UR-12670 against post-ischemic was calculated by the standard formula. At 12, 36, and 52 weeks, total serum cholesterol was measured by an thenamine, and Masson trichrome. Light microscopic sections were reviewed by a pathologist blinded to the enzymatic colorimetry method on an autoanalyzer (Beckman Instruments). treatment groups.
In acute experiments, sections were examined for sev-Renal function studies eral parameters of tubulointerstitial damage, including tubular dilation, tubular cell death and detachment, dys-At 52 weeks, animals were subjected to invasive functional studies to assess glomerular filtration rate and trophic calcifications, and interstitial edema and acute inflammation. For each case, a global estimation of the renal plasma flow and to measure arterial pressure. For this purpose, rats were anesthetized again with an intra-tubular lesion was made and semiquantitatively graded on a scale in which 0 was no abnormality, and 1ϩ, 2ϩ, 3ϩ, muscular mixture of ketamine/diazepam/atropine and were placed on a heating pad to maintain body tempera-and 4ϩ represented slight, mild, moderate, and severe abnormalities, respectively. ture at a physiological range. Vascular polyethylene catheters (PE-50) were implanted into the right carotid artery
In chronic experiments, glomerulosclerosis was assessed by examining at least 100 glomeruli in each kidney and right jugular vein. Arterial catheter was used for continuous monitoring of arterial pressure by means of and was expressed as the percentage of glomeruli presenting either segmental or global sclerosis and hya-an electronic pressure transducer (Nihon Kohden Co., Germany) and for blood sampling. A venous catheter linosis. Tubular (atrophy and dilation) and interstitial changes (fibrosis and mononuclear cell infiltrate), as well was used for the infusion of fluid and clearance markers. The abdominal cavity was opened, and the ureter was as arterial myointimal hyperplasia, were graded from 0 to 3ϩ (0, no changes; 1ϩ, changes affecting less than cannulated for the collection of urine with polyethylene tubing (PE-10). Rats received a priming load of inulin one third of the sample; 2ϩ, changes affecting between one and two thirds of the sample; 3ϩ, changes affecting (Polyfructosan; Laevosan, Linz, Austria) and paraaminohippuric acid (PAH; Merck, Darmstadt, Germany) (83 mg more than two thirds of the sample). In order to summarize the tubulointerstitial changes in each animal, a tubu-of inulin and 5 mg of PAH) via the right jugular vein, followed by a continuous infusion of a solution containing lointerstitial score was calculated by adding up the individual value of the tubular damage, interstitial fibrosis, 2% inulin and 0.6% PAH at a constant rate of 0.5 ml/ hr/100 g body wt. Urine collection was started after an and interstitial cell infiltrate. equilibration period of 60 minutes. Three periods of 20
In situ transforming growth factor-␤1 hybridization minutes were established to determine inulin and PAH clearances. At the midpoint of each period, 0.5 ml of Riboprobe for rat TGF-␤1 (298 pb; Clontech Laboratories, Palo Alto, CA, USA) was prepared by the reverse arterial blood was obtained. The inulin concentration in plasma and urine was determined by the indole-3-acetic transcription polymerase chain reaction (RT-PCR) using the 5Ј-primer, 5Ј-C TTC AGC TCC ACA GAG AAG acid (Merck) colorimetric assay. The PAH concentration in plasma and urine was measured by the colorimetric AAC TGC-3Ј, and 3Ј-primer, 5Ј-CAC GAT CAT GTT GGA CAA CTG CTC C-3Ј. Branson method. Glomerular filtration rate (GFR) and renal plasma flow (RPF), measured as inulin and PAH Reverse transcription-PCR was performed with RNA extracted from rat kidney serving as the template in clearances, respectively, were calculated by standard formulas, and the final result was the mean of the three a Thermal Cycler (Perkin Elmer Corp., Norwalk, CT, USA). Total RNA was obtained by the acid guanidine-values from each 20-minute period. It is well known that in chronic renal disease the PAH extraction ratio thiocyanate-phenol-chloroform method [17] , and 1 g of RNA was reverse transcribed to single-stranded cDNA is reduced, and thus, PAH clearance may underestimate true RPF in this setting. The absolute values of PAH by incubation with reverse transcription mixture [5 mm MgCl 2 , 10 mm Tris-HCl, pH 8.8, 50 mm KCl, 0.1% Triton clearance should therefore be considered with the caveat that a systematic error may exist. Nevertheless, PAH X-100, 1 mm dNTPs mixture, 50 ng oligo(dT) primer, 20 U RNasin, and 15 U reverse transcriptase from avian clearance was used as a comparative index of the putative changes in RPF occurring with each experiment. At the myeloblastosis virus; all from Promega, Madison, WI, USA]. Each PCR reaction containing 20 pmol of prim-end of the study, kidneys were perfused with a 4ЊC isotonic saline solution, removed, weighed, and processed ers, 0.5 Ci [␣ 32 P]dCTP (3000 Ci/mmol; Amersham, Arlington Heights, IL, USA) and 3 U Taq DNA polymerase for tissue studies.
was carried out under the following conditions: denatur-Light microscopy ing at 94ЊC for one minute, annealing at 60ЊC for one minute, and elongating at 72ЊC for two minutes. The ex-Coronal 1 to 2 mm thick slices of the kidney were fixed in 4% formaldehyde and embedded in paraffin, pression of glyceraldehyde-3-phosphate dehydrogenase was used as internal control. The PCR product was ligated and 3 to 4 m thick tissue sections were stained with hematoxylin and eosin, periodic acid-Schiff, silver me-into a PCR3 vector (Invitrogen, San Diego, CA, USA). ver's test. To analyze the correlation between proteinuria standard saline citrate (SSC), 1 ϫ Denhardt's, 0.1 m and cholesterol, the simple regression analysis was used. sodium phosphate pH 6.5, 10% dextran sulfate, 40%
All P values were two tailed, and a P value of Ͻ0.05 deionized formamide, 24 mm Vanadyl Ribonuclease was considered statistically significant. Data are precomplex, and 0.5 mg/ml yeast tRNA]. After washing in sented as mean Ϯ sem. 2 ϫ SSC for five minutes and 0.2 ϫ SSC for three minutes, sections were incubated with alkaline phosphatase conjugated antidigoxigenin antibody (1:750; Boehringer Mann-RESULTS heim). Colorimetric detection of mRNA was performed Effect of UR-12670 on ischemic acute renal failure with nitroblue tetrazolium and 5-bromo-4-chloro-3-indo-This effect was analyzed in two groups of warm ischelylphosphate in dark for 10 to 30 minutes. Negative conmic uninephrectomized rats (ischemic vs. UR-treated trols consisted of matched serial sections hybridized groups) followed for seven days. The mortality rate in without RNA probe, with sense probe and sections prethis set of acute experiments was 3 out of 11 in the treated with 25 g/ml RNAse A for 20 to 30 minutes ischemic group and 2 out of 10 in the UR-treated group. before hybridization with the corresponding antisense Thus, eight animals per group fulfilled the seven-day probe.
follow-up. Twenty-four hours after ischemia, both groups We separately evaluated the mRNA TGF-␤1 expresof rats displayed a similar degree of renal failure, as sion in glomeruli and tubules. The total number of posishown by the serum creatinine level (Table 1) . Nontive glomerular cells was counted in 30 glomeruli, and treated rats showed a further increase in serum creatinine the mean value was used as a glomerular index of TGFthat peaked on second day. Conversely, UR-12670-␤1 (number of positive cells/glomerulus). The extent of treated animals showed a progressive decline in serum tubular staining was assessed by means of a semiquanticreatinine on the second and third days. In fact, signifitative scale grading from 0 to 3ϩ. cant differences between groups were observed on the Statistical analysis second and third days. Seven days after ischemia, the serum creatinine level returned to the basal value only To compare the two groups, in acute experiments, in UR-treated rats, although no significant differences statistical analysis was performed by the U-Mann Whitbetween both groups were observed. ney method. In long-term experiments, the chi-square Concerning the histological evaluation, UR-treated test was used to compare the mortality ratio from acute animals showed a significantly lower acute tubulointerrenal failure between the treated and nontreated groups. stitial lesions induced by ischemia/reperfusion injury To compare more than two groups for proteinuria, serum than ischemic animals (Table 1) . creatinine, and creatinine clearance throughout the entire follow-up period, statistical analysis was performed Long-term effect of UR-12670 on renal functional by the one-way analysis of variance (ANOVA) for reparameters after warm renal ischemia in peated-measures method. To determine the origin of the uninephrectomized rats differences at any time point for these parameters, we
Considering all of the animals included for chronic used the one-way ANOVA for independent values folfollow-up studies, the mortality ratio from acute renal lowed by Scheffe's test. To compare histological and in failure in the first week after ischemia was higher in situ TGF-␤1 mRNA data, we used the nonparametric Kruskal-Wallis test for between-subject analysis fol-rats that did not receive UR-12670 during this period (SIK 16ϩ32ϩ52 and UR 8-E 52 , N ϭ 39) than in those animals sive arterial pressure among all of the experimental groups, although potentially, anesthesia may have modi-to which the PAF antagonist was administered (UR 0-7 52 and UR 0-E 16ϩ32ϩ52 , N ϭ 36, 35.9 vs. 13.9%, respec-fied this measure. The total serum cholesterol showed a progressive in-tively, P ϭ 0.03). No further mortality was observed during the follow-up periods in any of the groups.
crease in the SIK group throughout the experiment, although it remained unchanged in the rest of the groups After recovering from acute renal failure, the number of animals followed for 52 weeks was as follows: SK, (Table 2) . A strongly positive correlation was seen between proteinuria in the 12th week and total serum cho-N ϭ 7; SIK, N ϭ 9; UR 0-7, N ϭ 10; UR 8-E, N ϭ 8; UR 0-E, N ϭ 9. In the SIK group, proteinuria appeared lesterol in the 36th and 52nd weeks (P Ͻ 0.0001, r 2 ϭ 0.5, and P Ͻ 0.0001, r 2 ϭ 0.49, respectively). in the 12th week and showed a progressive increase throughout the entire follow-up (Fig. 1) . In UR-12670-Effect of UR-12670 on long-term renal morphology treated groups, proteinuria onset was delayed until the after warm renal ischemia in uninephrectomized rats 24th week, and it was significantly lower than in the SIK group throughout the experiment. There were no When analyzing histological parameters, the SIK group differences among the three treated groups at any time showed a significantly higher percentage of global glomerulosclerosis compared with SK (Table 3 ). All UR-point or along the entire follow-up. The SK group showed only mild proteinuria, which was similar to that 12670-treated groups showed a lower percentage of global glomerulosclerosis than SIK. In the UR 0-E in UR-12670 treated groups until the 40th week.
The serum creatinine level in the SIK group showed group, these differences began in the 16th week, were maintained in the 32nd week, and became statistically a slight and progressive increase from the 28th week, which became significantly higher beyond the 40th week significant in the 52nd week. When we extended the glomerulosclerosis quantitation to not only global glo-when compared with SK and UR 8-E groups (Fig. 2) . From week 48, significant differences were found be-merular alterations but also focal and segmental glomerulosclerosis, UR-12670-treated groups also showed sig-tween SIK and SK and both long-term treated groups (UR 0-E and UR 8-E). In week 52, the SIK group showed nificantly lower percentages than SIK. Nevertheless, when compared with SK, the UR 0-7 group displayed severe renal failure with a mean serum creatinine of 2.2 Ϯ 0.7 mg/dl. As shown in Figure 2 , only SIK and UR 0-7 significantly higher global and segmental glomerulosclerosis. On the contrary, in both long-term treated groups, rats developed chronic renal failure. Conversely, both long-term treated groups (UR 0-E and UR 8-E) showed glomerulosclerosis was not different from that in SK. When tubular atrophy, interstitial cell infiltrate, and similar serum creatinine values to those of SK group. Differences among groups in creatinine clearance through-fibrosis were analyzed, similar differences were observed between groups. In 16th and 32nd week, kidneys from out the study, as well as GFR and RPF values obtained at the end of the experiment, paralleled those of serum the SIK group showed some degree of tubulointerstitial injury, which was obvious in 52nd week (Fig. 3A ). As creatinine (Table 2) . No differences were found in inva-
Fig. 2. Effect of UR-12670 on serum creatinine
after warm renal ischemia in uninephrectomized rats. Symbols are: (Ⅲ; SK) single kidney, N ϭ 7; (᭹; SIK) single ischemic kidney, N ϭ 9; (᭝; UR 0-7) UR-12670 treated from 0 to 7 days, N ϭ 10; (ᮀ; UR 8-E) UR-12670 treated from the 8 th day until 52 weeks, N ϭ 8; (᭺; UR 0-E) UR-12670 treated from 0 to 52 weeks, N ϭ 9. In the SIK group, serum creatinine increased progressively from the 28th week, and it became significantly higher ( §) beyond the 40th week when compared with SK (P ϭ 0.04) and UR 8-E (P ϭ 0.04) groups. From the 48th week, significant differences (*) were found between the SIK and SK groups (P ϭ 0.03) and both long-term treated groups (UR 0-E, P ϭ 0.04; UR 8-E, P ϭ 0.02). By the one-way ANOVA for repeated-measures method, serum creatinine was higher in the SIK group than in the SK (P ϭ 0.0001), UR 0-E (P ϭ 0.0009) and UR 8-E (P Ͻ 0.0001) groups, and was similar to that in UR 0-7 group (P ϭ 0.3). Also, serum creatinine was higher in UR 0-7 group than in the UR 0-E (P ϭ 0.04), UR 8-E (P ϭ 0.008), and SK (P ϭ 0.01) groups. No differences were observed between the SK group and the UR 0-E (P ϭ 0.5) and UR 8-E (P ϭ 0.9) groups. Table 3 , kidneys from SIK group exhibited a ingly, kidneys from UR-12670-treated groups, in short and long-term schedules, had significantly fewer vascular higher level of tubulointerstitial damage than kidneys from the SK group, in which only minimal changes were lesions than kidneys from the SIK group. seen. When kidneys from the SIK group were compared Effect of UR-12670 on renal TGF-␤1 with the UR 0-7 group (Fig. 3B) , no significant differ-mRNA expression ences were found (tubulointerstitial score: SIK, 4.4 Ϯ 0.5; UR 0-7, 3.7 Ϯ 0.7, P ϭ 0.35). Conversely, both long-
The SIK group showed higher TGF-␤1 mRNA expression in glomerular (Figs. 3D and 4A) and tubular (Figs. term treatment groups (Fig. 3C ) showed significantly lower tubular atrophy, interstitial infiltrate, and fibrosis 3D and 4B) cells than the SK group. It is noteworthy that tubular staining disclosed focal distribution (Fig. than the SIK group (Table 3) .
Kidneys from the SK group showed no vascular abnor-3D). When analyzing UR-12670-treated groups, the TGF-␤1 mRNA glomerular index was similar in UR 0-7 malities throughout the follow-up. On the contrary, in the 32nd week and especially in the 52nd week, kidneys and SIK (Figs. 3E and 4A) animals. In both long-term UR-12670-treated groups (Fig. 3F) , the number of posi-from the SIK group had vascular myointimal hyperplasia with luminal narrowing of the affected vessels. Interest-tive glomerular cells was significantly lower than in the (Fig. 4A ). In this context, it has been proposed that further loss of nephrons because of initial ischemia may be critical [5, contrast, there were no significant differences in tubular 19] , and thus, these kidneys develop chronic renal dysstaining between all treated groups and kidneys from function by mechanisms described in the so-called hyperthe SIK group (Fig. 4E) .
filtration theory [20, 21] . Thus, models of a single kidney subjected to either warm or cold ischemia in uninephrec-DISCUSSION tomized rats are valuable tools to explore antigen-inde-In this work, we have shown that the administration pendent mechanisms of chronic transplant nephropathy of the PAF receptor antagonist UR-12670 attenuates [4, 22, 23] . the long-term effects of ischemia/reperfusion injury in The expression pattern of cellular and molecular mediuninephrectomized rats. Animals chronically receiving ators in the early [22] [23] [24] and late [5] stages after ische-UR-12670 have a delay in the onset and a reduction of mia/reperfusion injury has been previously reported. proteinuria, do not develop chronic renal failure, and Several groups, including ours [10, 11, 25] , have recently have a decrease in the glomerular TGF-␤1 mRNA exdescribed that PAF also plays a key role in the regulatory pression, as well as in the glomerulosclerosis and interstimechanisms of post-ischemic acute renal failure. In pretial fibrosis. This study also shows that protection from vious studies, we showed that a single intravenous injecpost-ischemic acute renal failure by a PAF antagonist tion of the PAF receptor antagonist, BN 52021, predelays and reduces proteinuria, but does not completely vented renal dysfunction and histological damage caused hamper the appearance of chronic renal failure and interby warm ischemia. Furthermore, in a model of cold ischestitial fibrosis. The beneficial effect of UR-12670, even mia, BN 52021 was able to overcome the functional damwhen given beyond the first week, that is, after the initial age induced by PAF [11] . Because UR-12670 has not ischemic injury has already occurred, strongly suggests been tested in warm renal ischemia, we started our study that PAF plays a role in the mechanisms of progression by analyzing the protection of renal ischemia/reperfusion of chronic renal damage.
injury by this agent. Results from the acute experiments There is some evidence suggesting that the nonimmuusing UR-12670 extend the observations mentioned in nological factor ischemia/reperfusion injury may be inthis section, showing that PAF receptor blockade attenuvolved in the pathogenesis of chronic transplant nephropaates the renal dysfunction and, even more interesting, thy [4, 18] . In renal transplantation, a 50% nephron mass the histological lesions induced by warm ischemia. The long-term impact of these initial functional and is usually offered because only one kidney is grafted. In mentioned studies, in which 45 minutes of renal ischemia were employed [26, 27] . Thus, treating only the initial ischemia/reperfusion injury with UR-12670 does not seem to be sufficient to completely prevent the progression to chronic organ dysfunction, especially after a severe renal ischemic injury.
We designed two other groups in order to ascertain whether PAF is involved in the progression to chronic renal damage after ischemia/reperfusion injury in uninephrectomized rats. According to the renal protective effect of UR-12670, we can assume that acute renal lesions secondary to ischemia/reperfusion injury could probably be higher in the UR 8-E group than in the UR 0-E group. However, the survivors from both long-term UR-12670-treated groups showed similar attenuation of chronic renal dysfunction and renal lesions. These findings suggest that after ischemia/reperfusion injury and apart from the severity of acute renal failure, long-term blockade of PAF receptor interferes with the mechanisms involved in the progression of chronic nephropathy. This is clearly supported by the lower proteinuria, mia [10, 11, 28, 29] . Our results suggest that PAF could also be considered as an important mediator of renal tissue matrix remodeling following ischemia in nephron mass ablation. The pathogenic mechanisms that lead to morphological benefits was analyzed by following animals chronic organ dysfunction in this situation remain parfor 52 weeks. Notably, short treatment with UR-12670 tially unknown, although ischemic organs are progresdelayed and reduced proteinuria and glomerulosclerosis, sively infiltrated by T cells and macrophages, mainly similarly to what occurred when prolonged long-term located in glomeruli and around vessels [5, 22, 23] . The treatment was used; however, these UR 0-7 treated ischepresence of these cell populations is associated with the mic rats disclosed late renal failure and severe chronic release of biological mediators, such as interleukin-1, tubulointerstitial lesions. These findings suggest that protumor necrosis factor-␣, TGF-␤1, endothelin-1, and the tection of post-ischemic acute renal failure by UR-12670 induction of nitric oxide synthase. Cells, cytokines, and only partially hindered the progression toward chronic chemoattractants, coupled with adhesion molecules, ininephropathy in this model. Other authors, treating posttiate a cascade that may ultimately stimulate proliferaischemic acute renal failure either by a soluble form of tion of arterial smooth muscle cells, glomerular mesan-P-selectin glycoprotein ligand [26] or by blocking the B7 gial cells, and fibroblasts [5, 30] . In various models of costimulatory pathway with CTLA4Ig [27] , found more chronic nephropathy, it has been demonstrated that inevident long-term protection against chronic renal infiltrating T cells and macrophages [31] as well as the intrinjury. A possible explanation may be that, in contrast to sic glomerular cells are sources of PAF [13, 14, 31, 32] . P-selectin glycoprotein ligand and CTLA4Ig treatment, In addition, several mediators, including endothelin-1, which fully protected kidneys from organ dysfunction induce the release of PAF by mesangial cells [33] . and leukocyte infiltration after ischemia/reperfusion in-Recent studies have shown that TGF-␤1 is a key fibrojury, UR-12670-treated kidneys were only partially progenic cytokine involved in the pathogenesis of chronic tected possibly because of the more prolonged warm nephropathy after ischemia and renal mass reduction ischemia we used. Moreover, ischemic untreated rats [5, 27] . In addition, in experimental models of chronic (SIK) developed chronic renal failure and achieved a renal injury, an overproduction of TGF-␤1 has been linked to the development of glomerulosclerosis [34, 35] . fivefold higher proteinuria than rats in the previously interstitial fibroblasts [14] , whether or not PAF acts di- by a direct effect [38, 39] or through the action of in-1997 flammatory cells [40] to induce proteinuria. It is known 7. Yasuda T, Kondo S, Homma T, Harris RC: Regulation of extracelthat abnormal glomerular permeability to proteins causes lular matrix by mechanical stress in rat glomerular mesangial cells. J Clin Invest 98:1991 -2000 proximal tubular cell dysfunction by enhancing the secre-
